Open Access

Table 1

HH pathway modulators.

Factor effected Functions Modulators References (PMID)
HH Antagonist RU-SKI 39
RU-SKI41
RU-SKI43
RU-SKI 50
[81]
SHH Block 5E1 [26]
PC Antagonist CA1
CA2
[142]
SMO Antagonist DHCEO
SMANT
KAAD-cyclopamine, Jervine
Saridegib
Vitamin D3
SEN450
[101]
[137]
[113]
[12]
[123]
[10]
[29]
SMO Agonist SAG
Purmorphamine, Oxysterols
Cholesterol,
PI4P
GSA-10
[30]
[105]
[69]
[63]
[47]
[33]
GLI Antagonist Arsenic trioxide [7]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.